Ninepoint Partners’s Camtek CAMT Stock Holding History

Ninepoint Partners’s Portfolio CAMT Stock Details CAMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13	Closed	-$1.97K	–	168
2026 Q1	$1.97K	Buy	+13	New	+$1.97K	﹤0.01%	148

Other funds holding CAMT

USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Y.D. More Investments Ramat Gan, Israel $3.21B AUM 117.29% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Ninepoint Partners's CAMT Position: Q2 2026 in Review

Ninepoint Partners sold out of Camtek (CAMT) in Q2 2026, closing a stake of 13 shares — an estimated $1.97K sold.

Ninepoint Partners first reported a position in CAMT in Q1 2026 and held it in 1 quarter. The position peaked at $1.97K in Q1 2026. 167 funds tracked by Wall St. Rank hold CAMT as of Q2 2026.

Ninepoint Partners reported no remaining Camtek position as of Q2 2026 after selling out during the quarter.
Ninepoint Partners sold 13 Camtek shares in Q2 2026, an estimated $1.97K.
Ninepoint Partners first reported a position in Camtek in Q1 2026 and held it in 1 quarter.
Ninepoint Partners's Camtek position peaked at $1.97K in Q1 2026.
167 funds tracked by Wall St. Rank held Camtek as of Q2 2026.

Based on Ninepoint Partners's 13F filing for Q2 2026, filed 11 Aug 2026.